Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects

NCT01675609 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Redness

Interventions

DRUG: Placebo
DRUG: Brimonidine tartrate 0.025%

Sponsor

Eye Therapies, LLC